An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Clinical trial NCT00936741 · COMPLETED
Trial details
- NCT number
- NCT00936741
- Sponsor
- Corcept Therapeutics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2012-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.